602-381-1091
info@hibcc.org
- Home
- Uncategorized
April 10, 2023
New HIN Authorized Licensee: Circulant Solutions Inc
To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]
March 24, 2023
The European Commission Is Now Seeking Public Input On Its Draft Delegated Act
A public consultation has been launched by the European Commission (EC) on its’ draft delegated act for highly individualized devices. The delegated act establishes the Master UDI-DI, a new identifier intended to group highly individualized devices according to clear clinic parameters. The Master UDI-DI solution was developed to reduce the volume of device records submitted […]
February 21, 2023
New HIN Authorized Licensee: Cipla, Inc.
To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]
January 30, 2023
New HIN Authorized Licensee: Agile Therapeutics
To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]
December 12, 2022
New HIN Authorized Licensee: CNECT
To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]
November 21, 2022
New HIN Authorized Licensee: Strides Pharma, Inc. & TG Therapeutics, Inc.
To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]
October 17, 2022
Register now for our HIBCC UDI Webinar
Gain insight into the European Union regulatory framework with overviews of key aspects including the Basic UDI-DI, EUDAMED, and more. To register for the HIBCC UDI Webinar: Intro to the EU MDR and IVDR click here. HIBCC is designated as an Issuing Entity by both the European Commission and the US FDA for their respective […]